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Available online 10 March 2016A 61 year old man presented to the emergency department (ED)
with constipation and vomiting for ten days. His blood pressureFig. 1. a. Axial contrast-enhanced abdominal computed
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and fever was 98.0% and 36.7 C, respectively. Hepatitis B carrier,
diabetes, hypertension, and hospitalization due to a mesenteric
panniculitis in last month were positive in his past medical history.
Abdominal distention and diffuse tenderness were noted. The
White blood cell count was 9.6  103/mL, while hemoglobin,
creatinine, urea, AST, ALT, total bilirubin, pH, and HCO3 were 12.8 g/
dL, 2.92 mg/dL, 29.9 mg/dL, 22 U/L, 17 U/L, 0.51 mg/dL, 7.30, and
19 mmol/s, respectively. Contrast-enhanced abdominal computed
tomography (CT) was performed to elucidate the etiology of
abdominal pain (Fig. 1AeB).tomography cross-section. b. Coronal cross-section.
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Fig. 2. a. The presence of thrombus in the portal vein (white arrow) b. In coronal sections thrombus is seen to extend to the renal vein (white arrow). The right and left kidneys are
consecutively 6.5 cm and 5.5 cm of length, this is suggestive for renal atrophy due to of chronic renal failure.
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Portal vein thrombosis, although rarely seen in a healthy pop-
ulation, is an usual complication in cirrhotic patients with 10e25%
prevalence during the course of the disease.1 It is also frequent in
the hypercoagulability settings such as malignancy and myelo-
proliferative disorders, etc.
Portal vein thrombosis may present as an acute or chronic
state. Since chronic portal vein thrombosis rarely produces se-
vere signs and symptoms, it is often detected through as an ac-
cident by using CT performed for other reasons.2 Abdominal pain,
bloody diarrhea, bloating, nausea, vomiting, splenomegaly, bowel
wall edema, and ischemia ﬁndings are more signiﬁcant for acute
portal vein thrombosis. Chronic portal vein thrombosis causes
symptoms as splenomegaly, varices, ascites, gastrointestinal
bleeding, obstructive jaundice, and hematologic disorders related
to portal hypertension.1e3 As the thrombosis may progress and
expand to the mesenteric vein, it may also cause abdominal pain
and bowel ischemia.4 Formation of collateral vessels (cavernous
transformation) is suggestive of chronic portal vein thrombosis.
Doppler imaging improves diagnostic accuracy, while contrast-
enhanced computed tomography and magnetic resonance im-
aging are the gold standard methods for detecting intestinal
ischemia and other complications of portal vein thrombosis.5
Anticoagulant therapy should be administered in acute portal
vein thrombosis to prevent thrombotic expansion, which may
complicate with acute bowel ischemia and portal hypertension.Anticoagulant therapy in patients with chronic portal vein throm-
bosis is controversial and should be decided according to the risk-
beneﬁt ratio.
In our case, thrombosis was observed in portal, superior
mesenteric, renal, and splenic vein. Chronic portal vein thrombosis
should be considered if the presence of mild symptoms and ex-
amination ﬁndings, spontaneous reduction of abdominal pain, and
collateral vasculature is shown by CT (Fig. 2AeB). The patient was
admitted to a general surgical department and anticoagulant
therapy was started. The patient was eventually discharged un-
eventfully ten days after admission.
Emergency physicians should consider portal vein thrombosis
as a cause of abdominal pain especially in cirrhotic patients.References
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